Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2003JAIDS Journal of Acquired Immune Deficiency Syndromes

Severe Hepatotoxicity During Combination Antiretroviral Treatment: Incidence, Liver Histology, and Outcome

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMassimo PuotiAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano NiguardaCTCarlo TortiUniversità Cattolica del Sacro CuoreDRDiego RipamontiOspedale Papa Giovanni XXIII

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Puoti et al. (2003) studied this question.

synapsesocial.com/papers/6a8308096e08aa851db37e1fhttps://doi.org/10.1097/00126334-200303010-00004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-19981999 · 148 citations
  2. 2Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy2001 · 353 citations
  3. 3Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients2000 · 115 citations